Your healthcare team can advise you on this
When you receive GLP-1 injections, the medication activates specific receptors in your brain and digestive system, resulting in increased feelings of fullness and satisfaction after eating
Start your intake Clinical Trial Data: Context and Individual Variation Tirzepatide's dual GLP-1 and GIP receptor agonism produced mean weight loss of 22.5% over 68 weeks in SURMOUNT-1 trials, compared to semaglutide's approximately 14-15% at comparable follow-up
Same caveat on 503A availability Branded GLP-1s Wegovy, Zepbound, Ozempic, Mounjaro available as cash-pay options Sublingual options daily oral troche format for patients who can't tolerate injections or want to titrate in California GLP-1 market context California requires that a patient-physician relationship be established before any prescription
However, healthcare providers must carefully monitor liver function tests throughout treatment, since enzyme elevations can occur
Before beginning any new drug or weight reduction program, always get advice from your healthcare professional
